First glimpses of the neurobiology of autism spectrum disorder

Current Opinion in Genetics and Development

Volumn 33, Issue , 2015, Pages 80-92

  Sanders, Stephan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 8; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA BINDING PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CHD8 PROTEIN, HUMAN; CHROMATIN; FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; TRANSCRIPTION FACTOR;

AUTISM; AUTOPSY; BRAIN NERVE CELL; CFTR GENE; CHD8 GENE; CHILDHOOD; CHROMATIN; CONVERGENT EVOLUTION; FMRP GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFANCY; MUTATIONAL ANALYSIS; NERVE CELL DIFFERENTIATION; NERVE PROJECTION; NEUROANATOMY; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STRIATAL MEDIUM SPINY NEURON; TRANSCRIPTION REGULATION; CHILD; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFANT; METABOLISM; NERVE CELL; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SYNAPSE; VISUAL CORTEX;

AUTISM SPECTRUM DISORDER; CHILD; CHILD, PRESCHOOL; CHROMATIN; DNA-BINDING PROTEINS; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT; INFANT, NEWBORN; NEURONS; SYNAPSES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VISUAL CORTEX;

EID: 84946545173     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2015.10.002     Document Type: Review

References (72)

1. Association A.P. Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Association, Washington, DC. 5th ed.
2. Grønborg T.K., Schendel D.E., Parner E.T. Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study. JAMA Pediatr 2013, 167:947-953.
3. Gaugler T., Klei L., Sanders S.J., Bodea C.A., Goldberg A.P., Lee A.B., Mahajan M., Manaa D., Pawitan Y., Reichert J., et al. Most genetic risk for autism resides with common variation. Nat Genet 2014, 46:881-885.
4. Sandin S., Lichtenstein P., Kuja-Halkola R., Larsson H., Hultman C.M., Reichenberg A. The familial risk of autism. JAMA 2014, 311:1770-1777.
5. Colvert E., Tick B., McEwen F., Stewart C., Curran S.R., Woodhouse E., Gillan N., Hallett V., Lietz S., Garnett T., et al. Heritability of Autism Spectrum Disorder in a UK Population-Based Twin Sample. JAMA Psychiatry 2015, 72:415-423.
6. Willsey A.J., State M.W. Autism spectrum disorders: from genes to neurobiology. Curr Opin Neurobiol 2015, 30:92-99.
7. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
8. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477-488.
9. Itsara A., Wu H., Smith J.D., Nickerson D.A., Romieu I., London S.J., Eichler E.E. De novo rates and selection of large copy number variation. Genome Res 2010, 20:1469-1481.
10. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region Are Strongly Associated with Autism. Neuron 2011, 70:863-885.
11. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
12. Pinto D., Delaby E., Merico D., Barbosa M., Merikangas A., Klei L., Thiruvahindrapuram B., Xu X., Ziman R., Wang Z., et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet 2014, 94:677-694.
13. Sanders S.J., He X., Willsey A.J., Ercan-Sencicek A.G., Samocha K.E., Cicek A.E., Murtha M.T., Bal V.H., Bishop S.L., Dong S., et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 2015, 87:1215-1233. 10.1016/j.neuron.2015.09.016.
14. Kumar R.A., KaraMohamed S., Sudi J., Conrad D.F., Brune C., Badner J.A., Gilliam T.C., Nowak N.J., Cook E.H., Dobyns W.B., et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628-638.
15. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675.
16. Moreno-De-Luca D., Moreno-De-Luca A., Cubells J.F., Sanders S.J. Cross-disorder comparison of four neuropsychiatric CNV loci. Curr Genet Med Rep 2014, 2:1-11.
17. Van der Aa N., Rooms L., Vandeweyer G., van den Ende J., Reyniers E., Fichera M., Romano C., Delle Chiaie B., Mortier G., Menten B., et al. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet 2009, 52:94-100.
18. Berg J.S., Brunetti-Pierri N., Peters S.U., Kang S.H., Fong C.T., Salamone J., Freedenberg D., Hannig V.L., Prock L.A., Miller D.T., et al. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet Med 2007, 9:427-441.
19. Depienne C., Heron D., Betancur C., Benyahia B., Trouillard O., Bouteiller D., Verloes A., LeGuern E., Leboyer M., Brice A. Autism, language delay and mental retardation in a patient with 7q11 duplication. J Med Genet 2007, 44:452-458.
20. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
21. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y-h Narzisi G., Leotta A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
22. Iossifov I., O'Roak B.J., Sanders S.J., Ronemus M., Krumm N., Levy D., Stessman H.A., Witherspoon K.T., Vives L., Patterson K.E., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014, 515:216-221.
23. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
24. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
25. Dong S., Walker M.F., Carriero N.J., DiCola M., Willsey A.J., Ye A.Y., Waqar Z., Gonzalez L.E., Overton J.D., Frahm S., et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep 2014, 9:16-23.
26. Nagy E., Maquat L.E. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 1998, 23:198-199.
27. He X., Sanders S.J., Liu L., De Rubeis S., Lim E.T., Sutcliffe J.S., Schellenberg G.D., Gibbs R.A., Daly M.J., Buxbaum J.D., et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet 2013, 9:e1003671.
28. De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Cicek A.E., Kou Y., Liu L., Fromer M., Walker S., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515:209-215.
29. Willsey A.J., Sanders S.J., Li M., Dong S., Tebbenkamp A.T., Muhle R.A., Reilly S.K., Lin L., Fertuzinhos S., Miller J.A., et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013, 155:997-1007.
30. Cutting G.R. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 2015, 16:45-56.
31. Schmeisser M.J., Ey E., Wegener S., Bockmann J., Stempel A.V., Kuebler A., Janssen A.L., Udvardi P.T., Shiban E., Spilker C., et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 2012, 486:256-260.
32. Rothwell P.E., Fuccillo M.V., Maxeiner S., Hayton S.J., Gokce O., Lim B.K., Fowler S.C., Malenka R.C., Südhof T.C. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014, 158:198-212.
33. Stefansson H., Meyer-Lindenberg A., Steinberg S., Magnusdottir B., Morgen K., Arnarsdottir S., Bjornsdottir G., Walters G.B., Jonsdottir G.A., Doyle O.M., et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 2014, 505:361-366.
34. Moreno-De-Luca A., Myers S.M., Challman T.D., Moreno-De-Luca D., Evans D.W., Ledbetter D.H. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol 2013, 12:406-414.
35. Deloukas P., Kanoni S., Willenborg C., Farrall M., Assimes T.L., Thompson J.R., Ingelsson E., Saleheen D., Erdmann J., Goldstein B.A., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013, 45:25-33.
36. State M.W., Šestan N. Neuroscience, The emerging biology of autism spectrum disorders. Science 2012, 337:1301-1303.
37. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011, 1380:42-77.
38. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
39. Bernier R., Golzio C., Xiong B., Stessman H.A., Coe B.P., Penn O., Witherspoon K., Gerdts J., Baker C., Vulto-van Silfhout A.T., et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 2014, 158:263-276.
40. Ascano M., Mukherjee N., Bandaru P., Miller J.B., Nusbaum J.D., Corcoran D.L., Langlois C., Munschauer M., Dewell S., Hafner M., et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 2012, 492:382-386.
41. O'Roak B.J., Vives L., Fu W., Egertson J.D., Stanaway I.B., Phelps I.G., Carvill G., Kumar A., Lee C., Ankenman K., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622.
42. Sugathan A., Biagioli M., Golzio C., Erdin S., Blumenthal I., Manavalan P., Ragavendran A., Brand H., Lucente D., Miles J., et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A 2014, 111:E4468-E4477.
43. Cotney J., Muhle R.A., Sanders S.J., Liu L., Willsey A.J., Niu W., Liu W., Klei L., Lei J., Yin J., et al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat Commun 2015, 6:6404.
44. Li J., Shi M., Ma Z., Zhao S., Euskirchen G., Ziskin J., Urban A., Hallmayer J., Snyder M. Integrated systems analysis reveals a molecular network underlying autism spectrum disorders. Mol Syst Biol 2014, 10:774.
45. Liu L., Lei J., Sanders S.J., Willsey A.J., Kou Y., Cicek A.E., Klei L., Lu C., He X., Li M., et al. DAWN: A framework to identify autism genes and subnetworks using gene expression and genetics. Mol Autism 2014, 5:22.
46. Chang J., Gilman S.R., Chiang A.H., Sanders S.J., Vitkup D. Genotype to phenotype relationships in autism spectrum disorders. Nat Neurosci 2015, 18:191-198.
47. Xu X., Wells A.B., O'Brien D.R., Nehorai A., Dougherty J.D. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci 2014, 34:1420-1431.
48. Basu S.N., Kollu R., Banerjee-Basu S. AutDB: a gene reference resource for autism research. Nucleic Acids Res 2009, 37:D832-D836.
49. Feldman I., Rzhetsky A., Vitkup D. Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci U S A 2008, 105:4323-4328.
50. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
51. Levy D., Ronemus M., Yamrom B., Lee Y.H., Leotta A., Kendall J., Marks S., Lakshmi B., Pai D., Ye K., et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011, 70:886-897.
52. Doyle J.P., Dougherty J.D., Heiman M., Schmidt E.F., Stevens T.R., Ma G., Bupp S., Shrestha P., Shah R.D., Doughty M.L., et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 2008, 135:749-762.
53. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., Sousa A.M., Pletikos M., Meyer K.A., Sedmak G., et al. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
54. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005, 4. Article17.
55. Ben-David E., Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol Psychiatry 2013, 18:1054-1056.
56. Miller J.A., Ding S.L., Sunkin S.M., Smith K.A., Ng L., Szafer A., Ebbert A., Riley Z.L., Royall J.J., Aiona K., et al. Transcriptional landscape of the prenatal human brain. Nature 2014, 508:199-206.
57. Parikshak N.N., Luo R., Zhang A., Won H., Lowe J.K., Chandran V., Horvath S., Geschwind D.H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
58. Abrahams B.S., Arking D.E., Campbell D.B., Mefford H.C., Morrow E.M., Weiss L.A., Menashe I., Wadkins T., Banerjee-Basu S., Packer A. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol Autism 2013, 4:36.
59. Bernard A., Lubbers L.S., Tanis K.Q., Luo R., Podtelezhnikov A.A., Finney E.M., McWhorter M.M., Serikawa K., Lemon T., Morgan R., et al. Transcriptional architecture of the primate neocortex. Neuron 2012, 73:1083-1099.
60. Lin G.N., Corominas R., Lemmens I., Yang X., Tavernier J., Hill D.E., Vidal M., Sebat J., Iakoucheva L.M. Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases. Neuron 2015, 85:742-754.
61. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
62. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., Salyakina D., Imielinski M., Bradfield J.P., Sleiman P.M., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
63. Gupta S., Ellis S.E., Ashar F.N., Moes A., Bader J.S., Zhan J., West A.B., Arking D.E. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun 2014, 5:5748.
64. Parellada M., Penzol M.J., Pina L., Moreno C., González-Vioque E., Zalsman G., Arango C. The neurobiology of autism spectrum disorders. Eur Psychiatry 2014, 29:11-19.
65. Kleijer K.T., Schmeisser M.J., Krueger D.D., Boeckers T.M., Scheiffele P., Bourgeron T., Brose N., Burbach J.P. Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl) 2014, 231:1037-1062.
66. Vichinsky E.P. Alpha thalassemia major - new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program 2009, 3:5-41.
67. Choi C.H., Schoenfeld B.P., Bell A.J., Hinchey P., Kollaros M., Gertner M.J., Woo N.H., Tranfaglia M.R., Bear M.F., Zukin R.S., et al. Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment. Brain Res 2011, 1380:106-119.
68. Michalon A., Sidorov M., Ballard T.M., Ozmen L., Spooren W., Wettstein J.G., Jaeschke G., Bear M.F., Lindemann L. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 2012, 74:49-56.
69. Gantois I., Pop A.S., de Esch C.E., Buijsen R.A., Pooters T., Gomez-Mancilla B., Gasparini F., Oostra B.A., D'Hooge R., Willemsen R. Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice. Behav Brain Res 2013, 239:72-79.
70. Pop A.S., Levenga J., de Esch C.E., Buijsen R.A., Nieuwenhuizen I.M., Li T., Isaacs A., Gasparini F., Oostra B.A., Willemsen R. Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacology (Berl) 2014, 231:1227-1235.
71. Choi C.H., Schoenfeld B.P., Weisz E.D., Bell A.J., Chambers D.B., Hinchey J., Choi R.J., Hinchey P., Kollaros M., Gertner M.J., et al. PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndrome. J Neurosci 2015, 35:396-408.
72. Gilman S.R., Chang J., Xu B., Bawa T.S., Gogos J.A., Karayiorgou M., Vitkup D. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci 2012, 15:1723-1728.